XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jul. 31, 2025
Jan. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,198,576 $ 1,349,380
Marketable securities 6,580,073 6,442,329
Accounts receivable, net of allowances of $22,901 and $22,078 as of July 31, 2025 and January 31, 2025, respectively 516,799 495,228
Deferred contract acquisition costs, current 177,498 188,358
Prepaid expenses and other current assets 190,260 200,679
Total current assets 8,663,206 8,675,974
Deferred contract acquisition costs, noncurrent 124,313 123,464
Property and equipment, net 301,457 330,475
Operating lease right-of-use assets 46,831 55,900
Strategic investments 647,908 591,481
Goodwill 307,295 307,295
Deferred tax assets 804,772 749,759
Other assets, noncurrent 148,281 154,073
Total assets 11,044,063 10,988,421
Current liabilities:    
Accounts payable 11,619 8,345
Accrued expenses and other current liabilities 471,017 558,562
Deferred revenue, current 1,465,044 1,336,387
Total current liabilities 1,947,680 1,903,294
Deferred revenue, noncurrent 14,233 17,274
Operating lease liabilities, noncurrent 32,015 37,406
Other liabilities, noncurrent 100,058 95,363
Total liabilities 2,093,986 2,053,337
Commitments and contingencies (Note 6)
Stockholders’ equity:    
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of July 31, 2025 and January 31, 2025; 267,284,079 and 263,113,866 shares issued and outstanding as of July 31, 2025 and January 31, 2025, respectively; 300,000,000 Class B shares authorized as of July 31, 2025 and January 31, 2025; 32,836,005 and 42,626,998 shares issued and outstanding as of July 31, 2025 and January 31, 2025, respectively 299 305
Additional paid-in capital 4,537,542 5,130,271
Accumulated other comprehensive (loss) income (477) 4,990
Retained earnings 4,412,713 3,799,518
Total stockholders’ equity 8,950,077 8,935,084
Total liabilities and stockholders’ equity $ 11,044,063 $ 10,988,421